BullBD Old Apps Site
Home
Favorites
Recently viewed Details Chart Today news Share news Top gainer Top Looser Upcoming events
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0 1 2 3 4 5 6 7 8 9 All
Bank Cement Ceramics Sector Corporate Bond Engineering Financial Institutions Food & Allied Fuel & Power IT Sector Insurance Jute Life Insurance Miscellaneous Mutual Funds Paper & Printing Pharmaceuticals & Chemicals Services & Real Estate Tannery Industries Telecommunication Textile Travel & Leisure All
  • Details
  • Chart
  • News

ORIONPHARM

All Eps Dividend Board Agm Q1 Q2 Q3

ORIONPHARM 15-Nov-2021

The EPS of Q1 (July '21 to September '21) has significantly decreased compared to the EPS of same period of last year due to no revenue generation from the two of the subsidiary companies namely Orion Power Meghnaghat Limited. and Dutch Bangla power & Associates Ltd. as their contract period has expired. However, the contract renewal with BPDB of the above two subsidiaries is under process.

ORIONPHARM 15-Nov-2021

(Q1 Un-audited): Consolidated EPS was Tk. 0.30 for July-September 2021 as against Tk. 0.82 for July-September 2020; Consolidated NOCFPS was Tk. 1.52 for July-September 2021 as against Tk. 1.46 for July-September 2020. Consolidated NAV per share (including revaluation surplus) was Tk. 80.55 as on September 30, 2021 and Tk. 79.76 as on June 30, 2021. Consolidated NAV per share (excluding revaluation surplus) was Tk. 72.59 as on September 30, 2021 and Tk. 71.79 as on June 30, 2021.

ORIONPHARM 09-Nov-2021

As per Regulation 16(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 14, 2021 at 4:00 PM to consider, among others, un-audited financial statements of the Company for the First Quarter (Q1) period ended on September 30, 2021.

ORIONPHARM 09-Nov-2021

There will be no price limit on the trading of the shares of the Company today (09.11.2021) following its corporate declaration.

ORIONPHARM 09-Nov-2021

(Continuation news of ORIONPHARM): The Company has reported Consolidated EPS of Tk. 4.01, Consolidated NAV per share (Including Revaluation Surplus) of Tk. 79.76, Consolidated NAV per share (Excluding Revaluation Surplus) of Tk. 71.79 and Consolidated NOCFPS of Tk. 11.07 for the year ended on June 30, 2021 as against Tk. 2.84, Tk. 76.77, Tk. 68.69 and Tk. 8.04 respectively for the same period of the previous year. (end)

ORIONPHARM 09-Nov-2021

The Board of Directors has recommended 12% cash dividend for the year ended on June 30, 2021. The Board has also considered and recommended the proposal for approval of the shareholders regarding Related Party Transaction for the Financial year ended June 30, 2021 and in this regard, the Board also advised to convene an EGM. Date of AGM and EGM: 19.12.2021, Time of AGM and EGM: 3:00 PM and 3:45 PM respectively, Venue: Digital Platform. Record Date for AGM and EGM: 29.11.2021. (Cont.)

ORIONPHARM 02-Nov-2021

As per Regulation 19(1) of the Dhaka Stock Exchange (Listing) Regulations, 2015, the Company has informed that a meeting of the Board of Directors will be held on November 08, 2021 at 4:00 PM to consider, among others, audited financial statements of the Company for the year ended on June 30, 2021.

ORIONPHARM 06-Oct-2021

In response to a DSE query dated October 04, 2021, the Company has informed that there is no undisclosed price sensitive information of the Company for recent unusual price hike and increase in volume of shares.

ORIONPHARM 12-Sep-2021

(Continuation news of ORIONPHARM): But as per our knowledge and understanding, no such proposal was placed or approved on that Cabinet Meeting. Therefore, this news article holds no credibility and we believe that a vested group is spreading such rumors in order to influence the Share Market of Bangladesh."

ORIONPHARM 12-Sep-2021

In response to a DSE query dated September 08, 2021, regarding clarification on recent news published in the newspaper, the Company has informed that "According to the news article, on September 06, 2021 the Cabinet gave Approval in Principle and Final Approval to extend the Quick Enhancement of Electricity and Energy Supply (Special Provision) Act 2010. (cont.)

Previous Next page